Neuronal imaging using SPECT.

Area of Science:

• Nuclear medicine
• Cardiology
• Medical imaging

Background:

• 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is a key method for evaluating cardiac sympathetic function.
• Cardiac sympathetic dysfunction is crucial in various heart diseases, with MIBG aiding in assessing severity, prognosis, and treatment efficacy, especially in heart failure, ischemic heart disease, and arrhythmias.
• Quantitative MIBG indices vary across institutions, and its evidence base in ischemic heart disease lags behind myocardial perfusion imaging.

Purpose of the Study:

• To provide fundamental information on 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy.
• To review the clinical utility of MIBG in various cardiac conditions.
• To discuss challenges and future directions for MIBG imaging.

Main Methods:

• This is a review article.
• It synthesizes existing literature on MIBG myocardial scintigraphy.
• Focuses on fundamental principles and clinical applications.

Main Results:

• MIBG scintigraphy provides objective data on cardiac sympathetic nerve activity.
• It is particularly valuable for evaluating heart failure, ischemic heart disease, and arrhythmias.
• Challenges include inter-institutional variability in quantitative indices and less established evidence in ischemic heart disease compared to perfusion imaging.

Conclusions:

• MIBG myocardial scintigraphy is a valuable tool for assessing cardiac sympathetic function.
• Further standardization and research are needed to solidify its role, particularly in ischemic heart disease.
• This review aims to guide understanding and application of MIBG imaging.